avexis

Novartis Gene Therapies is new name for gene therapy firm with growing RTP presence

Posted by WRAL TechWire | Sep 8, 2020

Novartis has announced the renaming of its previously acquired AveXis gene therapy arm because of “the growing importance of gene therapy to building a leading, focused medicines company with advanced therapy platforms.”

TechWire week in review: Surge of IT jobs, gene therapy firm expands + entrepreneur profiles, more

Posted by Shannon Cuthrell | Feb 25, 2019

Here is a rewind of the past week’s headlines as reported by WRAL TechWire.

Gene therapy firm to add 200 jobs, invest $60M in Durham county facility

Posted by WRAL TechWire | Feb 18, 2019

North Carolina’s global gene therapy leadership was boosted today with the announcement that AveXis, Inc., is doubling its planned workforce and investing $60 million more in its new Durham County manufacturing facility.

NC officials, biotech company AveXis announce expansion

Posted by WRAL TechWire | Feb 18, 2019

North Carolina may bring to an end today a recent streak of more bad news than good when it comes to economic development projects.

Novartis-owned AveXis bringing $55M gene therapy factory, 200 jobs to Durham

Posted by WRAL TechWire | May 22, 2018

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.